Evidence map›Paper›PMID 24804256›Full record

ReviewBioMed research international2014

Current trends in bone tissue engineering.

Marco Mravic, Bruno Péault, Aaron W James

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marco MravicDepartment of Pathology & Laboratory Medicine, and Orthopedic Hospital Research Center, University of California, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, A3-251 CHS, Los Angeles, CA 90095, USA.ORCID 0000-0001-6294-1824
Bruno PéaultDepartment of Pathology & Laboratory Medicine, and Orthopedic Hospital Research Center, University of California, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, A3-251 CHS, Los Angeles, CA 90095, USA.
Aaron W JamesDepartment of Pathology & Laboratory Medicine, and Orthopedic Hospital Research Center, University of California, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, A3-251 CHS, Los Angeles, CA 90095, USA.
University of California, Los Angeles · US

Funding

MARC U*STAR Program at the University of California, Los AngelesT34GM008563 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCEVOY, MEGAN M, POE, GINA R · 1996 to 2023
$9.7M
Medical Research Council G1000816NIGMS NIH HHS T34 GM008563
6 · The paper itself

Abstract

The development of tissue engineering and regeneration constitutes a new platform for translational medical research. Effective therapies for bone engineering typically employ the coordinated manipulation of cells, biologically active signaling molecules, and biomimetic, biodegradable scaffolds. Bone tissue engineering has become increasingly dependent on the merging of innovations from each of these fields, as they continue to evolve independently. This foreword will highlight some of the most recent advances in bone tissue engineering and regeneration, emphasizing the interconnected fields of stem cell biology, cell signaling biology, and biomaterial research. These include, for example, novel methods for mesenchymal stem cell purification, new methods of Wnt signaling pathway manipulation, and cutting edge computer assisted nanoscale design of bone scaffold materials. In the following special issue, we sought to incorporate these diverse areas of emphasis in order to reflect current trends in the field.

Indexed as

Biocompatible MaterialsBone RegenerationComputer-Aided DesignHumansMesenchymal Stem CellsTissue EngineeringTissue ScaffoldsWnt Signaling PathwayBiocompatible Materials

Identifiers

PMID24804256
PMCPMC3997160
OpenAlexW2062924394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.